Clinical Trials Sponsored by Reckitt and Colman

Total 430 results

U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine (EEE)

Eastern Equine Encephalitis

United States
Goldman, Butterwick, Fitzpatrick and Groff
LEO Pharma

Completed

Evaluate the Efficacy and Safety of Large-Scale Field-Directed Topical Therapy of Actinic Keratosis of the Chest w/Ingenol Mebutate 0.015%

Actinic Keratosis

United States
U.S. Army Medical Research and Development Command

Completed

Reference Values for Non-invasive Hydration Status Markers H10-14

Value Orientation

United States
U.S. Army Medical Research and Development Command

Completed

Western Equine Encephalitis Vaccine, Inactivated (WEE)

Virus

United States
U.S. Army Medical Research and Development Command

Completed

Phase 1 Safety and Immunogenicity of Meningococcal Vaccine (HOPS)

Meningococcal Infection, Group B

United States
U.S. Army Medical Research and Development Command

Completed

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

HIV Infections

United States
U.S. Army Medical Research and Development Command

Completed

Challenge Study of an ETEC Vaccine

Enteritis; Escherichia Coli, Enterotoxigenic

United States
U.S. Army Medical Research and Development Command

Completed

Invaplex 50 Vaccine Dose-Ranging

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Weekly Dosing of Malarone ® for Prevention of Malaria (MALWEEK)

Malaria

United States
U.S. Army Medical Research and Development Command

Recruiting

Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome

Hantaan Virus Nephropathy | Puumala Virus Nephropathy

United States
U.S. Army Medical Research and Development Command

Recruiting

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Recruiting

Intravenous Ribavirin Protocol to Treat Individuals With Viral Hemorrhagic Fever

Viral Hemorrhagic Fever

Germany
U.S. Army Medical Research and Development Command

Completed

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS) (MMB4(DMS))

Safety and Efficacy

United States
Casa Colina Hospital and Centers for Healthcare

Completed

Multimodal Investigation of Post COVID-19 in Females

Cognitive Dysfunction | Post COVID-19

United States
Casa Colina Hospital and Centers for Healthcare

Completed

Sensory Versus Motor Level Neuromuscular Electrical Stimulation (NMES)

Stroke, Ischemic

United States
U.S. Army Medical Research and Development Command

Available

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Smallpox | Monkeypox
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated (RVF)

Rift Valley Fever

United States
U.S. Army Medical Research and Development Command

Completed

Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54

Malaria,Falciparum

United States
U.S. Army Medical Research and Development Command

Completed

Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Active, not recruiting

Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine (VEE TC-83)

Venezuelan Equine Encephalomyelitis

United States
U.S. Army Medical Research and Development Command

Completed

Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine

Eastern Equine Encephalitis

United States
U.S. Army Medical Research and Development Command

Withdrawn

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

Malaria

United States
U.S. Army Medical Research and Development Command

Withdrawn

Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany (HFRS)

Hemorrhagic Fever With Renal Syndrome

Germany
U.S. Army Medical Research and Development Command

Completed

A Double-Blind, Randomized, Placebo Controlled, Clinical Trial of an Antiplaque Chewing Gum (30 mg) - Phase 2 Proof of Concept in a Generally Healthy Patient Population (APCG)

Plaque Regrowth
U.S. Army Medical Research and Development Command

Withdrawn

Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study

Diarrhea

United States
U.S. Army Medical Research and Development Command

Completed

Study of the Safety of Intravenous Artesunate

Malaria | Malaria, Cerebral

United States
U.S. Army Medical Research and Development Command

Completed

Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK)

Leishmaniasis, Cutaneous

Peru
U.S. Army Medical Research and Development Command

Completed

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

Escherichia Coli Infection

United States
U.S. Army Medical Research and Development Command

Completed

Hyperbaric Oxygen Therapy (HBO2) for Persistent Post-concussive Symptoms After Mild Traumatic Brain Injury (mTBI) (HOPPS)

Traumatic Brain Injury | Post-concussive Symptoms

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Sculptra to Aid in Treatment of Arm Laxity

Skin Laxity
Goldman, Butterwick, Fitzpatrick and Groff
Biofrontera Bioscience GmbH

Not yet recruiting

Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities

Skin Neoplasms

United States
Goldman, Butterwick, Fitzpatrick and Groff
Ilooda Co., Ltd.

Unknown

Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles

Aging | Wrinkle

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants

Dengue

Thailand
Goldman, Butterwick, Fitzpatrick and Groff
RoC Opco LLC

Not yet recruiting

Evaluating the Efficacy and Safety of Cleanser, Serum, and Sunscreen Products for Facial Redness.

Redness
Goldman, Butterwick, Fitzpatrick and Groff
Sofwave Medical LTD

Recruiting

High Intensity Ultrasound for the Treatment of Upper Inner Arm Skin Laxity

Skin Laxity

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Recruiting

Clinical Trial of Poly-L-lactic Acid (Sculptra Aesthetic) for the Treatment of Cellulite of the Buttocks and Thighs

Cellulite

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Completed

Sculptra Aesthetic for the Treatment of Upper Knee Skin Laxity

Knee | Lax Skin

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

Dengue

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Shock Syndrome

Puerto Rico
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

Dengue

Thailand
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S (MAL019)

Malaria, Falciparum

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Completed

A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children

Dengue Fever

Thailand
Goldman, Butterwick, Fitzpatrick and Groff
Mentor Worldwide, LLC

Unknown

A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines

Wrinkles

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell

Skin Laxity

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline

Terminated

Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults

Malaria | Plasmodium Vivax

Thailand
Goldman, Butterwick, Fitzpatrick and Groff
DUSA Pharmaceuticals, Inc.

Completed

A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

Actinic Keratoses

United States
VA Ann Arbor Healthcare System
U.S. Army Medical Research and Development Command

Completed

PROlonGed ExpoSure Sertraline (PROGrESS)

Posttraumatic Stress Disorder

United States
Georgetown University
U.S. Army Medical Research and Development Command

Completed

Exercise in Gulf War Illness (GWI)

Persian Gulf Syndrome | Gulf War Illness

United States
Neumedicines Inc.
U.S. Army Medical Research and Development Command

Completed

NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds

Colostomy Stoma

United States
U.S. Army Medical Research and Development Command
SmithKline Beecham

Completed

Evaluation of Weekly Tafenoquine

Malaria

Clinical Trials Sponsored by Reckitt and Colman

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations